Employing genetics-informed management of Severe Hypertriglyceridemia (SHTG)

Chief of Cardiology Baylor College of Medicine on Genetics-Informed Management of Severe Hypertriglyceridemia

Presented by Christie M. Ballantyne, MD, FACC, FAHA. Dr. Christie M. Ballantyne is the Chief of Cardiology, Director of the Center for Cardiometabolic Disease Prevention and Professor of Medicine and Human Genetics at the Baylor College of Medicine. Dr. Ballantyne has co-authored 900 peer-reviewed articles and textbooks on clinical lipidology and cardiovascular disease prevention and management. Dr. Ballantyne is globally recognized lecturer on the molecular genetics and medical management of cardiometabolic diseases.

In the Webinar, Dr. Ballantyne explores:

• Genetic architecture of severe hypertriglyceridemia (SHTG)
• The clinical utility of genetic testing in your patients with SHTG
• Employing genetics-informed management of your patients with SHTG